Finance

Lists
9995:HKG
Remegen Ord Shs H
HK$73.75
-0.87%
(-0.65) 1D
Sep 11, 4:08:54 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9995...
Open
HK$73.80
High
HK$74.30
Low
HK$71.75
Mkt. cap
62.43B
Avg. vol.
0.00
Volume
2.18M
P/E ratio
49.00
52-wk high
HK$126.60
52-wk low
HK$63.30
EPS
HK$1.51
No. of employees
3K
Open
HK$73.80
High
HK$74.30
Low
HK$71.75
Mkt. cap
62.43B
Avg. vol.
0.00
Volume
2.18M
P/E ratio
49.00
52-wk high
HK$126.60
52-wk low
HK$63.30
EPS
HK$1.51
No. of employees
3K
About Remegen Ord Shs H
CEOJianmin Fang
Employees3.14K
FoundedJul 4, 2008
Headquarters-
SectorBiotechnology
Websiteremegen.cn
Last report
Aug 24, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
5.20B / 2.69B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
621.88M
1.53B
656.21M
5.20B
Cost of goods sold
95.57M
144.90M
116.96M
134.14M
Cost of revenue
95.57M
144.90M
116.96M
134.14M
Research and development expenses
243.37M
328.16M
209.86M
204.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
366.19M
437.44M
355.27M
466.87M
Operating expense
613.06M
764.11M
561.33M
673.73M
Total operating expenses
708.64M
909.01M
678.29M
807.87M
Operating income
-86.76M
622.21M
-22.08M
4.39B
Other non operating income
-3.60M
4.44M
3.05M
-3.16M
EBT including unusual items
-101.13M
1.26B
328.49M
4.33B
EBT excluding unusual items
-98.47M
615.48M
-31.29M
4.38B
Income tax expense
-
748.69K
486.54K
104.76K
Effective tax rate
-
0.06%
0.15%
-
Other operating expenses
-1.60M
60.85K
1.78M
1.62M
Net income
-101.13M
1.26B
328.01M
4.33B
Net profit margin
-16.26%
82.31%
49.98%
83.40%
Earnings per share
-
-
-
-
Interest and investment income
1.13M
1.02M
1.10M
10.47M
Interest expense
-15.23M
-13.13M
-13.36M
-4.28M
Net interest expenses
-14.10M
-12.10M
-12.26M
6.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.01M
685.23M
40.94M
4.45B
Gain or loss from assets sale
178.55K
771.57K
-
1.26M
AI content may include mistakes. Learn more
Google apps